Evidence map›Paper›PMID 21695202›Full record

ArticlePloS one2011

Rising cyclin-CDK levels order cell cycle events.

Catherine Oikonomou, Frederick R Cross

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Multisite phosphorylation code of CDK.Nature structural & molecular biology · 2019
    Article
  6. Review
  7. PP2AMolecular cell · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Cell cycle control by a minimal Cdk network.PLoS computational biology · 2015
    Article
  13. Stretched cell cycle model for proliferating lymphocytes.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  14. Multisite phosphorylation networks as signal processors for Cdk1.Nature structural & molecular biology · 2013
    Article
  15. A Wee1 checkpoint inhibits anaphase onset.The Journal of cell biology · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Catherine OikonomouLaboratory of Cell Cycle Genetics, The Rockefeller University, New York, New York, United States of America.
Frederick R Cross
Rockefeller University · US

Funding

SPECIFICITY OF CYCLIN FUNCTION AT CELL CYCLE INITIATIONR01GM047238 · NIGMS · ROCKEFELLER UNIVERSITY · PI CROSS, FREDERICK R. · 1993 to 2010
$3.4M
Sources and Consequences of noise in cell cycle regulationR01GM078153 · NIGMS · ROCKEFELLER UNIVERSITY · PI CROSS, FREDERICK R. · 2006 to 2019
$3.3M
NIGMS NIH HHS GM47238NIGMS NIH HHS R01 GM047238NIGMS NIH HHS R01 GM078153
6 · The paper itself

Abstract

backgroundDiverse mitotic events can be triggered in the correct order and time by a single cyclin-CDK. A single regulator could confer order and timing on multiple events if later events require higher cyclin-CDK than earlier events, so that gradually rising cyclin-CDK levels can sequentially trigger responsive events: the "quantitative model" of ordering. METHODOLOGY/PRINCIPAL

findingsThis 'quantitative model' makes predictions for the effect of locking cyclin at fixed levels for a protracted period: at low cyclin levels, early events should occur rapidly, while late events should be slow, defective, or highly variable (depending on threshold mechanism). We titrated the budding yeast mitotic cyclin Clb2 within its endogenous expression range to a stable, fixed level and measured time to occurrence of three mitotic events: growth depolarization, spindle formation, and spindle elongation, as a function of fixed Clb2 level. These events require increasingly more Clb2 according to their normal order of occurrence. Events occur efficiently and with low variability at fixed Clb2 levels similar to those observed when the events normally occur. A second prediction of the model is that increasing the rate of cyclin accumulation should globally advance timing of all events. Moderate (<2-fold) overexpression of Clb2 accelerates all events of mitosis, resulting in consistently rapid sequential cell cycles. However, this moderate overexpression also causes a significant frequency of premature mitoses leading to inviability, suggesting that Clb2 expression level is optimized to balance the fitness costs of variability and catastrophe. CONCLUSIONS/SIGNIFICANCE: We conclude that mitotic events are regulated by discrete cyclin-CDK thresholds. These thresholds are sequentially triggered as cyclin increases, yielding reliable order and timing. In many biological processes a graded input must be translated into discrete outputs. In such systems, expression of the central regulator is likely to be tuned to an optimum level, as we observe here for Clb2.

Indexed as

Cell CycleAnaphaseCyclin-Dependent KinasesCyclinsModels, BiologicalSchizosaccharomycesSchizosaccharomyces pombe ProteinsSpindle ApparatusTime FactorsCyclin-Dependent KinasesCyclinsSchizosaccharomyces pombe Proteins

Identifiers

PMID21695202
PMCPMC3112166
OpenAlexW2060821036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.